Anti-DLL3 antibody drug conjugates
US9867887B1 · kind B1 · utility
7Cited by
47References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 1, 2017 |
| Grant date | Jan 16, 2018 |
| Priority date | — |
| Expiry date | Sep 1, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70596
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.